Hepatic Zonation in MASLD: Old Question, New Challenge in the Era of Spatial Omics
International Journal of Molecular Sciences · 03.11.2025 · 26 (21) · 10701
DOI: 10.3390/ijms262110701 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2025. Verfasst von Erika Paolini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicine and Metabolic Diseases, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy. Hauptthemen laut MEDLINE: Liver, Metabolomics, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della salute, Italian Ministry of Health, Bando Ricerca Corrente and Piano Nazionale Complementare Ecosistema Innovativo della Salute—Hub Life Science-Diagnostica Avanzata.
Abstract (Originalsprache)
Hepatic zonation reflects the concept that hepatocytes and nonparenchymal cells (NPCs) perform distinct metabolic functions, depending on their spatial localization along the porto-central axis. The maintenance of this fine-tuned organization is essential for liver homeostasis, and its disruption may contribute to liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD). Fat overload perturbs zonal gene signatures, lipid handling and oxygen/metabolite gradients progressively leading to steatohepatitis (MASH), fibrosis and HCC, conditions in which the hepatic architecture is lost. Traditional approaches have provided valuable insights into zonation, although they lack the spatial resolution and mask the heterogeneity of NPCs. Thus, the premise of this review is to discuss how spatial omics can redefine our understanding of hepatic zonation by integrating tissue mapping with metabolic organization, specifically focusing on MASLD. The advent of spatial omics accelerates knowledge regarding MASLD pathophysiology, providing more informative insights into transcriptional/translational/lipidomic/metabolomics zone-specific perturbations. Emerging spatial genomics and epigenomics applications further expand this scenario, allowing for the capture of chromatin remodeling in situ. The integration of these state-of-the-art approaches, coupled with artificial intelligence (AI)-based analyses, is promising in the clinic, as it may provide novel zonal prognostic biomarkers and pave the way for precision-medicine strategies targeting zonal switching.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine and Metabolic Diseases, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, 20122 Milan, Italy.
ORCID-Profile: Miriam Longo, Marica Meroni, Paola Dongiovanni
Förderung
- Ministero della salute
- Italian Ministry of Health
- Bando Ricerca Corrente and Piano Nazionale Complementare Ecosistema Innovativo della Salute—Hub Life Science-Diagnostica Avanzata
- Italian Ministry of Education and Research (MUR): Dipartimenti di Eccellenza Program
Zitieren
APA
Paolini, E., Longo, M., Meroni, M., & Dongiovanni, P. (2025). Hepatic Zonation in MASLD: Old Question, New Challenge in the Era of Spatial Omics. International Journal of Molecular Sciences, 26(21), 10701. https://doi.org/10.3390/ijms262110701
Vancouver
Paolini E, Longo M, Meroni M, Dongiovanni P. Hepatic Zonation in MASLD: Old Question, New Challenge in the Era of Spatial Omics. International Journal of Molecular Sciences. 2025;26(21):10701. doi:10.3390/ijms262110701
BibTeX
@article{Paolini2025,
author = {Paolini, Erika and Longo, Miriam and Meroni, Marica and Dongiovanni, Paola},
title = {Hepatic Zonation in MASLD: Old Question, New Challenge in the Era of Spatial Omics},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10701},
doi = {10.3390/ijms262110701}
}
EUVIMED